The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheums’ offices everywhere this year, and at #EULAR2021, data presented from Israel, has provided much-needed answers. https://t.co/PUa6deflTy https://t.co/cs4MwnIcdR